Studies Evaluating Effectiveness of Risk Minimisation Measures

被引：0
|
作者：
Francisca, R. D. C. [1 ]
Zomerdijk, I. M. [1 ]
Sturkenboom, M. C. J. M. [1 ]
Straus, S. M. J. M. [1 ]
机构：
[1] Erasmus MC, Med Informat, Rotterdam, Netherlands
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2016年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
713
引用
收藏
页码：416 / 416
页数：1
相关论文
共 50 条
  • [31] Review of Studies Evaluating Effectiveness of Risk Minimization Measures Assessed by the European Medicines Agency Between 2016 and 2021
    Grupstra, Renske J.
    Goedecke, Thomas
    Scheffers, Jet
    Strassmann, Valerie
    Gardarsdottir, Helga
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (06) : 1285 - 1292
  • [32] Objectives and Design of the Post-Authorization Studies Evaluating the Effectiveness of the Risk Minimization Measures in the EU PAS Register
    Farcas, A.
    Huruba, M.
    Mogosan, C.
    DRUG SAFETY, 2018, 41 (11) : 1133 - 1133
  • [33] Evaluation of Effectiveness of Risk Minimisation Activities for Vandetanib in Canada
    Moride, Y.
    Salvo, F.
    Kozmenko, M.
    Frise, S.
    DRUG SAFETY, 2013, 36 (09) : 834 - 834
  • [34] A web-based survey of UK pharmacists to assess the effectiveness of Viagra Connect® additional risk minimisation measures
    Joanna Lem
    Janine Collins
    Terry Maguire
    Rachel E. Sobel
    International Journal of Clinical Pharmacy, 2022, 44 : 608 - 618
  • [35] Process Indicators vs. Correlated Endpoints in Studies Evaluating the Effectiveness of Risk Minimization Measures in the EU PAS Register
    Farcas, A.
    Huruba, M.
    Mogosan, C.
    DRUG SAFETY, 2018, 41 (11) : 1137 - 1137
  • [36] Limitations in evaluating effectiveness of risk minimization measures: A qualitative analysis of industry sponsored post-authorization safety studies
    Grupstra, Renske
    Goedecke, Thomas
    Gardarsdottir, Helga
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 636 - 637
  • [37] Reporting Quality of Evaluations of Additional Risk Minimisation Measures by MAH: An Assessment of Studies Submitted in the European Union
    Okai, J.
    Bahri, P.
    Sarinic, V. Macolic
    DRUG SAFETY, 2021, 44 (12) : 1402 - 1403
  • [38] Additional Risk Minimisation Measures to Prevent Medication Error in the EU
    Artime, Esther
    Qizilbash, Nawab
    Rubino, Annalisa
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 291 - 291
  • [39] JAK inhibitor safety information updated with risk minimisation measures
    Reactions Weekly, 2023, 1951 (1) : 2 - 2
  • [40] Additional risk minimisation measures in the EU- are they eligible for assessment?
    Zomerdijk, Inge M.
    Trifiro, Gianluca
    Sayed-Tabatabaei, Fakhredin A.
    Sturkenboom, Miriam C. J. M.
    Straus, Sabine M. J. M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 (10) : 1046 - 1053
12345